Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Apr;51(4):572–573. doi: 10.1136/ard.51.4.572

Normal production of neutrophil activating peptide 1/interleukin 8 in monocytes from subjects with previous yersinia triggered reactive arthritis.

H Repo, M Ristola, M Leirisalo-Repo, A Walz, M Baggiolini
PMCID: PMC1004721  PMID: 1586266

Full text

PDF
572

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baggiolini M., Walz A., Kunkel S. L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989 Oct;84(4):1045–1049. doi: 10.1172/JCI114265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Granfors K., Jalkanen S., Lindberg A. A., Mäki-Ikola O., von Essen R., Lahesmaa-Rantala R., Isomäki H., Saario R., Arnold W. J., Toivanen A. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet. 1990 Mar 24;335(8691):685–688. doi: 10.1016/0140-6736(90)90804-e. [DOI] [PubMed] [Google Scholar]
  3. Hoogkamp-Korstanje J. A., de Koning J., Samsom J. P. Incidence of human infection with Yersinia enterocolitica serotypes O3, O8, and O9 and the use of indirect immunofluorescence in diagnosis. J Infect Dis. 1986 Jan;153(1):138–141. doi: 10.1093/infdis/153.1.138. [DOI] [PubMed] [Google Scholar]
  4. Keat A., Thomas B., Dixey J., Osborn M., Sonnex C., Taylor-Robinson D. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet. 1987 Jan 10;1(8524):72–74. doi: 10.1016/s0140-6736(87)91910-6. [DOI] [PubMed] [Google Scholar]
  5. Koivuranta-Vaara P., Leirisalo-Repo M., Repo H. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease. Ann Rheum Dis. 1987 Apr;46(4):307–313. doi: 10.1136/ard.46.4.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Koivuranta-Vaara P., Repo H., Leirisalo M., Kiistala U., Osterman T., Vapaatalo H. Enhanced neutrophil migration in vivo HLA B27 positive subjects. Ann Rheum Dis. 1984 Apr;43(2):181–185. doi: 10.1136/ard.43.2.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Leirisalo-Repo M., Suoranta H. Ten-year follow-up study of patients with Yersinia arthritis. Arthritis Rheum. 1988 Apr;31(4):533–537. doi: 10.1002/art.1780310410. [DOI] [PubMed] [Google Scholar]
  8. Leirisalo M., Repo H., Tiilikainen A., Kosunen T. U., Laitinen O. Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum. 1980 Sep;23(9):1036–1044. doi: 10.1002/art.1780230911. [DOI] [PubMed] [Google Scholar]
  9. Pease C. T., Fordham J. N., Currey H. L. Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27. Ann Rheum Dis. 1984 Apr;43(2):279–284. doi: 10.1136/ard.43.2.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Repo H., Koivuranta-Vaara P., Leirisalo-Repo M. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations. Ann Rheum Dis. 1988 Jun;47(6):452–457. doi: 10.1136/ard.47.6.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Repo H., Ristola M., Leirisalo-Repo M. Enhanced inflammatory reactivity in the pathogenesis of spondyloarthropathies. Autoimmunity. 1990;7(4):245–254. doi: 10.3109/08916939009087584. [DOI] [PubMed] [Google Scholar]
  12. Walz A., Peveri P., Aschauer H., Baggiolini M. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Commun. 1987 Dec 16;149(2):755–761. doi: 10.1016/0006-291x(87)90432-3. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES